Montreal Heart Institute

This study aims to find the best aspirin regimen for people with type 2 diabetes who don't respond well to standard low-dose aspirin. Researchers will test different doses and formulations (enteric-coated vs. chewable) in 30 participants to see which one most effectively prevents…

This study is testing if taking just one blood-thinning drug (ticagrelor) is better than the standard two-drug combo (ticagrelor plus aspirin) for people who have had a heart attack and are being treated with medication alone. It aims to see if the single drug reduces the risk of…

This study is testing whether a personalized IV fluid plan can prevent kidney damage that sometimes occurs after common heart procedures like angiograms or stents. Over 1,100 patients will receive either a standard fluid rate or a rate adjusted based on their heart pressure and t…

This large study is testing whether two existing, low-cost medications—colchicine (an anti-inflammatory) and aspirin (a blood thinner)—can prevent serious heart problems in people with type 2 diabetes who are at high risk. It will enroll 10,000 adults aged 55-80 who have diabetes…

This study is testing whether a program that combines physical exercise with brain training games can improve memory, thinking speed, and overall brain function in people living with chronic heart failure. Researchers will enroll 216 men and women to compare the combined program …

This study aims to find out if the timing of a cholesterol test during a hospital stay for a heart attack affects the treatment plan a patient receives. Researchers will observe about 100 patients, testing their cholesterol levels on the day they are admitted and again two days l…

This study aims to use artificial intelligence (AI) to analyze past heart valve procedures and improve predictions for future surgeries. Researchers will look at medical scans and records from 21,000 people who have already undergone specific heart valve treatments. The goal is t…

This is the first study in people to test the safety of avenanthramide, a natural compound found in oats that may have anti-inflammatory properties. Researchers will give single and multiple doses to healthy volunteers and to people with a larger waist size and low-grade inflamma…